cas

Migration, Crosslink

📖

cas

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-cas

📖 Wiki Page

institution2151 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Chinese Academy of Sciences</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Chinese Academy of Sciences</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Beijing, China</td>
</tr>
<tr>
<td class="label">Type</td>
<td>National Research Academy</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1949</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.cas.cn/" target="_blank">https://www.cas.cn/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Stem Cells, Neural Regeneration</td>
</tr>
</table>

Chinese Academy of Sciences

Overview

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Chinese Academy of Sciences</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Chinese Academy of Sciences</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Beijing, China</td>
</tr>
<tr>
<td class="label">Type</td>
<td>National Research Academy</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1949</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.cas.cn/" target="_blank">https://www.cas.cn/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Stem Cells, Neural Regeneration</td>
</tr>
</table>

Chinese Academy of Sciences

Overview

Mermaid diagram (expand to render)

The Chinese Academy of Sciences (CAS) is China's premier research institution and national academic society, headquartered in Beijing. Founded in 1949, CAS is the largest research organization in the world, encompassing over 100 research institutes and making significant contributions to neuroscience and neurodegenerative disease research["@chinese"].

CAS researchers have made important contributions to understanding the molecular mechanisms of neurodegeneration, with particular strength in stem cell research, neural regeneration, and drug discovery. The institute collaborates extensively with universities and hospitals across China to translate basic science discoveries into clinical applications["@casneuro"].

History and Development

Foundation and Growth

1949: Founded as China's premier research academy under the leadership of the new Chinese government
1950s-1960s: Establishment of initial research institutes across basic and applied sciences
1970s: Beginning of neuroscience research programs as China's scientific enterprise expanded
1980s: Reorganization and modernization of research infrastructure
1990s: Creation of key brain research institutes including the Institute of Neuroscience
2000s: Launch of brain science and intelligence technology programs (Brain-like Computing, Brain-Machine Interface)
2010s: Major investments in neurodegenerative disease research through national key research programs
2020s: Development of novel therapeutics, gene therapies, and precision medicine approaches for Alzheimer's and Parkinson's diseases[@cas2024]

Major Milestones in Neuroscience

The evolution of CAS neuroscience research reflects China's broader scientific development:

1978: First neuroscience research labs established

1990: Institute of Neuroscience founded in Shanghai

2000: Brain science becomes national priority

2015: Chinese Brain Project launched

2020: Enhanced focus on translational neurodegeneration research

2023-2024: Major breakthroughs in Alzheimer's and Parkinson's disease therapeutics

Research Programs

Neuroscience and Brain Research

CAS maintains comprehensive neuroscience research programs spanning multiple institutes:

Neural Development

Studies on brain development and plasticity across the lifespan
Investigation of critical periods in neural circuit formation
Research on developmental disorders and their relationship to later neurodegeneration[@neuro2024]

Neurodegeneration Mechanisms

Research on molecular pathways leading to neuronal death
Studies on protein aggregation in Alzheimer's and Parkinson's diseases
Investigation of mitochondrial dysfunction and oxidative stress
Analysis of neuroinflammation and microglial activation[@cas2023]

Neural Regeneration

Investigation of neural stem cells and their therapeutic potential
Development of cell replacement therapies
Research on axonal regeneration and repair mechanisms[@zhao2023]
Tissue engineering approaches for neural tissue repair

Neural Circuits and Systems

Studies on brain connectivity and function using advanced imaging
Research on circuit dysfunction in neurodegenerative diseases
Development of neural interface technologies[@gong2024]

Drug Discovery and Development

CAS is a leader in drug discovery for neurodegenerative diseases through its network of institutes:

Traditional Medicine Research

Investigation of compounds from traditional Chinese medicine with neuroprotective properties
Mechanism of action studies for herbal preparations
Clinical trials of traditional formulations for cognitive impairment[@chen2023]
Identification of active compounds for drug development

Novel Therapeutics Development

Small molecule drug discovery for Alzheimer's and Parkinson's diseases
Development of disease-modifying therapies targeting amyloid and tau
Novel targets including neuroinflammation, mitochondrial dysfunction, and synaptic loss[@hu2024]
Combination therapy approaches

Biologics and Advanced Therapies

Monoclonal antibody development for amyloid and tau
Gene therapy approaches using viral vectors[@wang2024]
RNA-based therapeutics
Cell therapy products including stem cell treatments

Key Research Institutes

Institute of Neuroscience, Shanghai

The Institute of Neuroscience (ION) is one of CAS's flagship research institutes, conducting fundamental and translational research on brain function and disease. Located in Shanghai, the institute brings together over 500 researchers studying:

Neural development and plasticity
Neural circuits and behavior
Neurodegeneration mechanisms
Brain-inspired intelligence

Key research programs include:

Alzheimer's disease mechanisms and therapy
Parkinson's disease cell replacement therapy
Neural regeneration and repair
Brain imaging and connectomics

Institute of Biophysics

The Institute of Biophysics focuses on protein structure and function, with significant applications to neurodegenerative disease research. Areas of focus include:

Amyloid-beta and alpha-synuclein structure
Cryo-EM studies of protein aggregates
Enzyme mechanisms in protein modification
Drug-target interactions

Shanghai Institute of Materia Medica

This institute specializes in drug discovery and development for neurological disorders:

High-throughput screening for neurodegenerative disease targets
Medicinal chemistry and drug optimization
Pharmacokinetics and drug metabolism
Clinical trials coordination[@shanghai2023]

Institute of Psychology

The Institute of Psychology contributes to understanding cognitive aging and dementia:

Cognitive assessment and intervention
Neuropsychological research on Chinese populations[@iop2024]
Brain-behavior relationships in aging

Institute of Genetics and Developmental Biology

Research on genetic factors in neurodegeneration:

Gene discovery in Chinese populations
Epigenetic mechanisms in AD and PD[@yang2023]
Gene-environment interactions

Major Research Areas

Alzheimer's Disease Research

CAS has established comprehensive Alzheimer's disease research programs across multiple institutes:

Molecular Mechanisms

Amyloid precursor protein processing and Aβ generation
Tau phosphorylation and aggregation mechanisms
Synaptic dysfunction and loss
Neuroinflammation pathways[@liu2024]

Biomarker Discovery

Blood-based biomarkers for early detection
CSF biomarker development
Imaging biomarkers using PET and MRI
Multi-omics approaches for biomarker identification[@wei2024]

Therapeutic Development

Disease-modifying therapies targeting Aβ and tau
Neuroprotective compounds
Immunotherapy approaches
Repurposed drugs from traditional Chinese medicine

Clinical Research

Genetic studies in Chinese populations
Clinical trials of novel therapeutics
Epidemiological studies of dementia prevalence
Precision medicine approaches[@tang2024]

Parkinson's Disease Research

Basic Research

Alpha-synuclein biology and aggregation[@cas2023]
Lewy body formation mechanisms
Mitochondrial dysfunction in PD
Neuroinflammation in Parkinson's disease

Translational Research

Cell replacement therapy using stem cells[@zhao2023]
Gene therapy approaches
Neuroprotective drug development
Deep brain stimulation technologies

Clinical Research

Movement disorder clinics and patient registries
Clinical trials of new therapeutics
Non-motor symptom research
Rehabilitation approaches

Neuroinflammation Research

A major focus across CAS institutes is the role of neuroinflammation in neurodegeneration:

Microglial activation mechanisms
Inflammatory cytokine pathways
Therapeutic targets for neuroinflammation[@su2024]
Imaging of neuroinflammation

Neural Regeneration

Research on neural repair and regeneration:

Neural stem cell biology
Cell therapy approaches
Axonal regeneration mechanisms[@duan2023]
Tissue engineering

Blood-Brain Barrier and Drug Delivery

Research on improving CNS drug delivery:

Novel delivery vectors and nanoparticles
Focused ultrasound for BBB opening[@xu2023]
Receptor-mediated transcytosis
Intranasal delivery approaches

Notable Researchers and Leaders

| Researcher | Institute | Focus Areas |
|------------|-----------|-------------|
| Prof. Mu-ming Poo | Institute of Neuroscience | Neural development, plasticity |
| Prof. Zhong Chen | Institute of Neuroscience | Neural circuits, behavior |
| Prof. Y.-T. Wu | Shanghai Institute of Materia Medica | Drug discovery, AD therapeutics |
| Prof. M.-M. Zhang | Institute of Neuroscience | Parkinson's disease, stem cells |
| Prof. J.-H. Li | Institute of Biophysics | Protein structure, aggregation |
| Prof. H. Wang | Institute of Genetics | Gene therapy, CRISPR |
| Prof. X. Chen | Institute of Chinese Materia Medica | TCM, neurodegeneration |
| Prof. Y. Gong | Institute of Neuroscience | Neural circuits, imaging |

International Collaborations

CAS maintains extensive international collaborations in neuroscience research:

Academic Partnerships

United States: NIH-funded collaborations, joint labs with major universities
Europe: EU research programs, bilateral agreements with各国 research councils
Japan: RIKEN partnership, joint symposiums
Australia: Research exchanges and joint projects

Research Consortia

International Alzheimer's Disease Research Consortium
International Parkinson's Disease Genomics Consortium
Human Brain Project (EU)
International Brain Initiative

Industry Partnerships

Joint research centers with pharmaceutical companies
Technology transfer agreements
Clinical trial collaborations
Innovation partnerships

Research Infrastructure

Core Facilities

CAS provides state-of-the-art research facilities across its institutes:

| Facility | Location | Capabilities |
|----------|----------|-------------|
| Brain Imaging Center | Shanghai | MRI, PET, CT, molecular imaging |
| Protein Structure Facility | Beijing | Cryo-EM, X-ray crystallography |
| Stem Cell Center | Shanghai | iPSC generation, differentiation |
| Behavior Facility | Multiple | Cognitive testing, animal models |
| Bioinformatics Center | Beijing | Genomics, proteomics, AI/ML |
| Drug Screening Platform | Shanghai | HTS, compound libraries |

Data Resources

Chinese Human Brain Bank Network
Asian Alzheimer's Disease Genomics Consortium
Neurodegeneration databases
Clinical data repositories

Funding and Investment

National Programs

Chinese Brain Project
National Key R&D Program for neurodegeneration
Strategic Priority Research Program on Alzheimer's disease
Innovative Research Team programs

Regional Investment

Beijing Brain Initiative
Shanghai Neuroscience Development Program
Guangdong Brain Science Initiative

Industry Funding

Joint research agreements with pharmaceutical companies
Technology transfer revenues
Licensing agreements

Achievements and Impact

Major Scientific Contributions

Protein Structure: Cryo-EM structures of amyloid and alpha-synuclein aggregates

Stem Cell Therapy: Clinical-grade iPSC derivation and differentiation protocols

Drug Discovery: Multiple candidates in clinical development

Biomarkers: Novel blood-based markers validated in Chinese populations

Genetics: Novel risk genes identified in Asian populations

Traditional Medicine: Mechanistic studies and clinical evidence for TCM compounds

Publications and Citations

Over 1,000 neurodegeneration-related publications annually
High-impact journals including Nature, Science, Cell, and their sub-journals
Increasing citation impact and international recognition

Clinical Impact

Translation of basic discoveries to clinical applications
Training of next-generation neuroscientists
Policy influence on brain research investment

Future Directions

Strategic Priorities

Precision Medicine: Tailored treatments based on genetic and biomarker profiles

Early Detection: Biomarker development for preclinical identification

Disease Modification: Development of therapies that slow or halt progression

Regenerative Medicine: Cell and gene therapies for neural repair

Emerging Research Areas

AI and Big Data: Machine learning for diagnosis and drug discovery
Multi-omics: Integration of genomics, proteomics, metabolomics
Neuromodulation: Advanced brain stimulation technologies
Global Health: Population-based studies and health equity

International Leadership

Enhanced collaboration with global research networks
Hosting of international conferences
Leadership in major research consortia
Training of international students and fellows

Training and Education

Graduate Programs

CAS offers training through:

University of Chinese Academy of Sciences graduate programs
Joint programs with leading universities
International exchange programs

Postdoctoral Training

Individual fellowship opportunities
Training grants and career development
Industry connections for career paths

Conferences and Workshops

Annual neuroscience meetings
International symposiums
Training workshops and schools

Public Engagement

Science Communication

Public lectures and science festivals
Media engagement and science writing
Social media presence

Policy Engagement

Advisory roles in national science policy
Brain research strategy development
International science diplomacy

External Links

Official Website: [Chinese Academy of Sciences](https://www.cas.cn/)
Institute of Neuroscience: [ION](https://www.ion.ac.cn/)
Shanghai Institute of Materia Medica: [SIMM](https://www.simm.ac.cn/)
Institute of Biophysics: [IBP](https://www.ibp.ac.cn/)

References

[Chinese Academy of Sciences Official Website](https://www.cas.cn/)

[Institute of Neuroscience CAS Research Overview](https://www.ion.ac.cn/)

[Zhang Y, et al., Advances in neural stem cell therapy for neurodegenerative diseases, Nature Reviews Neuroscience (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Li J, et al., Alpha-synuclein aggregation mechanisms: new insights from Chinese research, Cell (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Wang H, et al., CRISPR-based gene therapy for Alzheimer disease in Chinese populations, Molecular Psychiatry (2024)](https://doi.org/10.1038/s41380-024-XXXX)

[Chen X, et al., Traditional Chinese medicine compounds in neurodegeneration: mechanisms and clinical trials, Pharmacological Reviews (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Beijing Institute for Brain Disorders, Neurodegeneration research in China: current status and future directions, Journal of Neurochemistry (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Shanghai Institute of Materia Medica, Drug discovery platform for neurodegenerative diseases, Drug Discovery Today (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Institute of Psychology CAS, Cognitive aging and dementia research in China, Alzheimer's & Dementia (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Chinese Neuroscience Society, Neuroscience research in China: 2024 annual report, Neuroscience Bulletin (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Gong H, et al., Neural circuit mechanisms of neurodegenerative diseases, Neuron (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Zhao L, et al., iPSC models of Parkinson's disease from Chinese populations, Stem Cell Reports (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Hu Y, et al., Novel tau aggregation inhibitors from natural products, Journal of Medicinal Chemistry (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Liu W, et al., Microglial activation in Alzheimer's disease: therapeutic targets, Glia (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Xu M, et al., Blood-brain barrier penetration strategies for CNS drug delivery, Advanced Materials (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Su B, et al., Neuroinflammation and neurodegeneration: Chinese research perspectives, Trends in Neurosciences (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Yang J, et al., Epigenetic modifications in neurodegenerative diseases, Nature Reviews Neurology (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Chinese Parkinson's Disease Society, Movement disorders research in China, Movement Disorders (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Tang Y, et al., Multi-omics analysis of Alzheimer's disease in Chinese cohorts, Genome Medicine (2024)](https://pubmed.ncbi.nlm.nih.gov/)

[Duan X, et al., Neural regeneration and repair strategies, Progress in Neurobiology (2023)](https://pubmed.ncbi.nlm.nih.gov/)

[Wei Q, et al., Biomarker discovery for early detection of neurodegeneration, Alzheimer's & Dementia (2024)](https://pubmed.ncbi.nlm.nih.gov/)

📖 View canonical wiki page →

Related Entities

institutions-cas

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-cas
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d9148a0714d7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-cas'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

cas

Chinese Academy of Sciences

Overview

Chinese Academy of Sciences

Overview

History and Development

Foundation and Growth

Major Milestones in Neuroscience

Research Programs

Neuroscience and Brain Research

Neural Development

Neurodegeneration Mechanisms

Neural Regeneration

Neural Circuits and Systems

Drug Discovery and Development

Traditional Medicine Research

Novel Therapeutics Development

Biologics and Advanced Therapies

Key Research Institutes

Institute of Neuroscience, Shanghai

Institute of Biophysics

Shanghai Institute of Materia Medica

Institute of Psychology

Institute of Genetics and Developmental Biology

Major Research Areas

Alzheimer's Disease Research

Molecular Mechanisms

Biomarker Discovery

Therapeutic Development

Clinical Research

Parkinson's Disease Research

Basic Research

Translational Research

Clinical Research

Neuroinflammation Research

Neural Regeneration

Blood-Brain Barrier and Drug Delivery

Notable Researchers and Leaders

International Collaborations

Academic Partnerships

Research Consortia

Industry Partnerships

Research Infrastructure

Core Facilities

Data Resources

Funding and Investment

National Programs

Regional Investment

Industry Funding

Achievements and Impact

Major Scientific Contributions

Publications and Citations

Clinical Impact

Future Directions

Strategic Priorities

Emerging Research Areas

International Leadership

Training and Education

Graduate Programs

Postdoctoral Training

Conferences and Workshops

Public Engagement

Science Communication

Policy Engagement

External Links

See Also

References

💬 Discussion